ТРАНСАНАЛЬНАЯ ТОТАЛЬНАЯ МЕЗОРЕКТУМЭКТОМИЯ ПРИ РАКЕ ПРЯМОЙ КИШКИ (обзор литературы)

трансанальная тотальная мезоректумэктомия, рак, ТА-ТМЕ1

1. Расулов А.О., Мамедли З.З., Кулушев В.М. и соавт. Миниинвазивные технологии в хирургии рака прямой кишки. Колопроктология. - 2014. - 2 (47). - с. 28-37.

2. Чернышов С.В., Орлова Л.П., Жданкина С.Н. и соавт. Высокая частота скрытой малигниза-ции ворсинчатых опухолей, как фактор выбора трансанальных эндоскопических операций. Колопроктология. - 2013. - № 2 (44) - с. 3-8.

3. Heald R.J., Husband E.M., Ryall R.D. The mesorectum in rectal cancer surgery-the clue to pelvic recurrence? Br. J. Surg. - 1982. - № 69 - p. 613-616.

4. Heald R.J. The «Holy Plane» of rectal surgery. J.R. Soc. Med. - 1988. - № 81 - p. 503-508.

5. Goldberg S., Klas J.V. Total mesorectal excision in the treatment of rectal cancer: a view from the USA. Semin. Surg. Oncol. - 1998. - № 15 - p. 87-90.

6. Heald R.J. Total mesorectal excision is optimal surgery for rectal cancer: a Scandinavian consensus. Br. J. Surg. - 1995. - № 82 - p. 1297-1299.

7. Heald R.J. Total mesorectal excision. Acta Chir. Iugosl. - 1998. - № 45. - p. 37-38.

8. MacFarlane J.K., Ryall R.D., Heald R.J. Mesorectal excision for rectal cancer. Lancet. - 1993. - № 341 (8843). - p. 457-460.

9. Peeters K.C., Marijnen C.A., Nagtegaal I.D. et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann. Surg. - 2007. - № 246 (5) - p. 693-701.

10. Bosch S.L., Nagtegaal I.D. The importance of the pathologist’s role in assessment of the quality of the mesorectum. Curr. Colorectal Cancer Rep. - 2012. -№ 8 (2) - p. 90-98.

11. Quirke P., Durdey P., Dixon M.F. et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. - 1986. -№ 2 - p. 996-9.

12. Nagtegaal I.D., Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J. Clin. Oncol. - 2008. - № 26 (2) -p. 303-12.

13. Leite J.S., Martins S.C., Oliveira J. et al. Clinical significance of macroscopic completeness of mesorectal resection in rectal cancer. Colorectal Dis. - 2011. - № 13 (4) - p. 381-6.

14. Quirke P., Steele R., Monson J. et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO 16 randomised clinical trial. Lancet. - 2009. -№ 373 (9666). - p. 821-8.

15. Nagtegaal I.D., van Krieken J.H. The multidisciplinary treatment of rectal cancer: pathology. Ann. Oncol. - 2007. - № 18 Suppl 9: ix - p. 122-6.

16. Garcia-Granero E., Faiz O., Munoz E. et al. Macroscopic assessment of mesorectal excision in rectal cancer: a useful tool for improving quality control in a multidisciplinary team. Cancer. - 2009. -№ 115 (15). - p. 3400-11.

17. Nagtegaal I.D., van de Velde C.J., van derWorp E. et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J. Clin. Oncol. - 2002. № 20 (7). -p. 1729-34.

18. Köckerling F., Gastinger I., Schneider B. at al. Laparoscopic abdominoperineal excision of the rectum with high ligation of the inferior mesenteric artery in the management of rectal carcinoma. Endosc. Surg. Allied Technol. - 1993. - № 1. - p. 144-150.

19. Vennix S., Pelzers L., Bouvy N. et al. Laparoscopic versus open total mesorectal excision for rectal cancer (Review). The Cochrane Library. - 2014. - Issue 4.

20. Jayne D.G., Thorpe H.C., Copeland J. et al. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br. J. Surg. - 2010. -№ 97 - p. 1638-1645.

21. Bonjer H.J., Deijen C.L., Abis G.A. et al. A randomized trial of laparoscopic versus open surgery for rectal cancer. N. Engl. J. Med. - 2015. - № 372. -p. 1324-1332.

22. Jeong S.Y., Park J.W., Nam B.H. et al. Open versus laparoscopic surgery for mid-rectal or lowrectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomized controlled trial. Lancet Oncol. - 2014. -№ 15. - p. 67-774.

23. Kang S.B., Park J.W., Jeong S.Y. et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREANtrial): short-termoutcomes of an open-label randomised controlled trial. Lаncet Oncol. - 2010. -№ 11. - p. 637-645.

24. Jayne D.G., Thorpe H.C., Copeland J. et al. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br. J. Surg. - 2010. -№ 97. - p. 1638-1645.

25. Sam Hee Kim, Ki Beom Bae, Jung Min Kim et al. Oncologic Outcomes and Risk Factors for Recurrence after Tumor-specific Mesorectal Excision of Rectal Cancer: 782 Cases. J. Korean. Soc. Coloproctol. - 2012. - № 28 (2). - p. 100-107.

26. VanderPas M.H., Haglind E., Cuesta M.A. et al. Colorectal cancer Laparoscopic or Open Resection II (COLOR II) Study Group. Laparoscopic versus open surgery for rectal cancer (COLOR II): shot-term outcomes of randomized, phase 3 trial. Lancet Oncol. - 2013. - № 14 - p. 210-2.

27. Kang B.S., Park J.W., JeongJ.Y. et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol. - 2010. -№ 11 - p. 637-645.

28. Akiyoshi T., Kuroyanagi H., Oya M. et al. Factors affecting the difficulty of laparoscopic total mesorectal excision with double stapling technique anastomosis for low rectal cancer. Surgery. - 2009. - № 146. -p. 483-489.

29. Ito M., Sugito M., Kobayashi A. at al. Relationship between multiple numbers of staplerfirings during rectal division and anastomotic leakage after laparoscopic rectal resection. Int. J. Colorectal Dis. -2008. - № 23 (7). - p. 703-707.

30. Marks J.M., Ponsky J.L, Pearl J.P. et al. PEG «Rescue»: a practical NOTES technique. SurgEndosc. -2007. - № 21. - p. 816-819.

31. Michalik M., Orlowski M., Bobowicz M. et al. A. The first report on hybrid NOTES adjustable gastric banding in human. Obes. Surg. - 2011. - № 21. -p. 524-527.

32. Palanivelu C., Rangarajan M., Jategaonkar P.A. et al. An innovative technique for colorectal specimen retrieval: a new era of «natural orifice specimen extraction (N.O.S.E.). Dis. Colon Rectum. - 2008. -№ 51 (7). - p. 1120-1124.

33. Franklin M.E.Jr., Ramos R., Rosenthal D. et al. Laparoscopic colonic procedures. World J. Surg. -1993. - № 17 (1). - p. 51-6.

34. Buess G., Theiss R., Hutterer F. et al. Transanal endoscopic surgery of the rectum-testing a new method in animal experiments. Leber. Magen. Darm. -1983. - № 13. - p. 73-7.

35. Bach S.P., Hill J., Simson J.N. Association of Coloproctology of Great Britain and Ireland Transanal Endoscopic Microsurgery (TEM) Collaboration. A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer. Br. J. Surg. - 2009. - № 96. - p. 280-290.

36. Whiteford M.H., Denk P.M., Swanstro'm L.L. Feasibility of radical sigmoid colectomy performed as natural orifice translumenalendoscopicsurgery (NOTES) using transanal endoscopic microsurgery. Surg. Endosc. - 2007. - № 21. - p. 1870-1874.

37. Sylla P., Willingham F.F., Sohn D.K. et al. NOTES rectosigmoid resection using transanal endoscopic microsurgery (TEM) with transgastric endoscopic assistance: a pilot study in swine. J. Gastrointest. Surg. - 2008. - № 12. - p. 1717-1723.

38. Jorgren, Johansson R., Damber L. et al. Risk factors of rectal cancer local recurrence: population-based survey and validation of the Swedish rectal cancer registry. Colorectal Disease. - № 12. -p. 977-986.

39. Sylla P., Rattner D.W., Delgado S. et al. NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg. Endosc. - 2010. - № 24. - p. 1205-1210.

40. Lacy А.M., Tasende M.M., Delgado S. et al. Transanal total mesorectal excision for rectal cancer: outcomes after 140 patients. J. Am. Coll. Surg. - 2015.

41. Albert M., Atallah S., DeBeche-Adams T. et al. Transanal minimally invasive surgery (TAMIS) for local excision of benign neoplasms and earl-stage rectal cancer: efficacy and outcomes in the first 50 patients. Dis. Colon Rectum. - 2013. - № 56. - p. 301-307.

42. Chouillard E., Chahine E., Khoury G. et al. Notes total mesorectal excision (TME) for patients with rectal neoplasia: a preliminary experience. Surg. endosc. - 2014. - № 28. - p. 3150-7.

43. Zorron R., Phillips H.N., Wynn G. et al. «Down-to-Up» transanal NOTES Total mesorectal excision for rectal cancer: Preliminary series of 9 patients. J. Minim. Access. Surg. - 2014. - № 10. - p. 144-50.

44. Choi B.J., Lee S.C., Kang W.K. Single-port laparoscopic total mesorectal excision with transanal resection (transabdominal transanal resection) for low rectal cancer: initial experience with 22 cases. Int. J. Surg. - 2013. - № 11. - p. 858-63.

45. Zhang H., Zhang Y.S., Jin X.W. et al. Transanal single-port laparoscopic total mesorectal excision in the treatment of rectal cancer. Tech. Coloproctol. - 2013. - № 17. - p. 117-23.

46. Leroy J., Barry B.D., Melani A. et al. No-scar transanal total mesorectal excision: the last step to pure NOTES for colorectal surgery. JAMA Surg. - 2013. - № 148. - p. 226-30; discussion 31.

47. Atallah S., Martin-Perez B., Pinan J. et al. Robotic transanal total mesorectal excision: a pilot study. Tech. Coloproctol. - 2014. - № 18. - p. 1047-53.

48. Angelis N., Portigliotti L., Azoulay D. et al. Transanal total mesorectal excision for rectal cancer: a single center experience and systematic review of the literature. Langenbecks Arch. Surg.

49. Guyatt G.H., Oxman A.D., Vist G.E. et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. - 2008. -№ 336. - p. 924-926.

50. Bj0rn M.X., Perdawood.S.K. Transanal total mesorectal excision - a systematic review. Dan. Med. J. - 2015. - № 62/7.

51. Arezzo A., Passera R., Scozzari G. Laparoscopy for rectal cancer reduces short-term mortality and morbidity: results of a systematic review and metaanalysis. Surg Endosc. - 2013. - № 27. - p. 1485-1502.

52. Tuech J.J., Karoui M., Lelong B. et al. A step toward NOTES total mesorectal excision for rectal cancer: endoscopic transanal proctectomy. Ann. Surg. - 2015. - № 261. - p. 228-33.

53. Muratore A., Mellano A., Marsanic P. et al. Transanal total mesorectal excision (taTME) for cancer located in the lower rectum: Short-and midterm results. Eur. J. Surg. Oncol. - 2015. - № 41. -p. 478-83.

54. Marks G.J., Marks J.H., Mohiuddin M. et al. Radical Sphincter preservation surgery with coloanal anastomosis following high-dose external irradiation for the very low lying rectal cancer. Recent Results Cancer Res. - 1998. - № 146. - p. 161-174.

55. Lacy A.M., Rattner D.W., Adelsdorf er C. et al. Transanal natural orifice transluminal endoscopic surgery (NOTES) rectal resection: «down-to-up» total mesorectal excision (TME) - short-term outcomes in the first 20 cases. Surg. Endosc. - № 27. - p. 31653172.

56. Rouanet P., Mourregot A., Azar C.C. et al. Transanal endoscopic proctectomy: an innovative procedure for difficult resection of rectal tumors in men with narrow pelvis. Dis. Colon Rectum. - 2013. -№ 56. - p. 408-15.

57. Fernandez-Hevia M., Delgado S., Castells A. et al. Transanal total mesorectal excision in rectal cancer: short-term outcomes in comparison with laparoscopic surgery. Ann. Surg. - 2015. - № 261 - p. 221-227.

58. Atallah S., Martin-Perez B., Albert M. et al. Transanal minimally invasive surgery for total mesorectal excision (TAMIS-TME): results and experience with the first 20 patients undergoing curative-intent rectal cancer surgery at a single institution. Tech. Coloproctol. - 2014. - № 18. -p. 473-80.

59. Ferko A., Maly O., Orhalmi J. et al. CT/MRI pelvimetry as a useful tool when selecting patients with rectal cancer for transanal total mesorectal exision. Surg. Endosc. - 2015.

60. https://tatme.medicaldata.eu